Skip to content

A comparative study of remimazolam dosing based on different body weight parameters for sedation anesthesia during gastroscopy in obese patients

A comparative study of remimazolam dosing based on different body weight parameters for sedation anesthesia during gastroscopy in obese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124317
Enrollment
Unknown
Registered
2026-05-11
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

TBW group (Total body weight group):The induction dose of remimazolam is 0.2 mg/kg based on total body weight, administered intravenously over a period of more than 30 seconds.
LBW group (Lean Body Weight group):The induction dose of remimazolam is 0.2 mg/kg based on lean body weight, administered intravenously over a period of more than 30 seconds.
IBW group (Ideal Body Weight group):The induction dose of remimazolam is 0.2 mg/kg based on ideal body weight, administered intravenously over a period of more than 30 seconds.
ABW group (Adjusted Body Weight group):The induction dose of remimazolam is 0.2 mg/kg based on adjusted body weight, administered intravenously over a period of more than 30 seconds.

Sponsors

The Affiliated Cancer Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–65 years; 2.American Society of Anesthesiologists (ASA) Physical Status I–III; 3.Body mass index (BMI) = 28 kg/m².

Exclusion criteria

Exclusion criteria: 1.Known allergy to benzodiazepines or any of their excipients; 2. Difficult airway; 3.Long-term use of sedative-hypnotics or opioids; 4.Pregnancy or lactation; 5.Psychiatric or neurological disorders that preclude cooperation with the assessment.

Design outcomes

Primary

MeasureTime frame
Successful sedation;

Secondary

MeasureTime frame
Systolic blood pressure before anesthesia induction;Diastolic blood pressure before anesthesia induction;Mean arterial pressure before anesthesia induction;Heart rate before anesthesia induction;The correlation between the weight parameters used during sedation and BMI.;The postoperative recovery indicators were evaluated using the QoR-15 assessment questionnaire within 24 hours.;Motor response;Injection pain;Systolic blood pressure at loss of consciousness;Diastolic blood pressure at loss of consciousness;Mean arterial pressure at loss of consciousness;Heart rate at loss of consciousness;Systolic blood pressure during gastroscope insertion;Diastolic blood pressure during gastroscope insertion;Mean arterial pressure during gastroscope insertion;Heart rate during gastroscope insertion;Systolic blood pressure at 1 minute after gastroscope insertion;Diastolic blood pressure at 1 minute after gastroscope insertion;Mean arterial pressure at 1 minute after gastroscope insertion;Heart rate at 1 minute after gastroscope insertion;Systolic blood pressure at 3 minutes after gastroscope insertion;Diastolic blood pressure at 3 minutes after gastroscope insertion;Mean arterial pressure at 3 minutes after gastroscope insertion;Heart rate at 3 minutes after gastroscope insertion;Incidence of hypoxemia;Incidence of apnea;Anesthesia induction time;Total sedation time;Time to full alertness;Operation duration;Time to discharge after anesthesia;Patient satisfaction with the operation;Endoscopist satisfaction with the operation;

Countries

China

Contacts

Public ContactWang Yue, Meng Fufen

The Affiliated Cancer Hospital of Xinjiang Medical University

1548869011@qq.com+86 150 2295 2844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026